| Literature DB >> 32974451 |
Helena Tizón-Marcos1,2,3, Iris Rodríguez-Costoya1,2,3, Cristina Tevar1,2, Beatriz Vaquerizo1,2,3.
Abstract
BACKGROUND: In-stent restenosis is a difficult percutaneous scenario if calcific neoatherosclerosis is the underlying aetiology. CASEEntities:
Keywords: Case report; Drug-eluting stent; Intracoronary lithotripsy; Plaque modification; Restenosis
Year: 2020 PMID: 32974451 PMCID: PMC7501907 DOI: 10.1093/ehjcr/ytaa117
Source DB: PubMed Journal: Eur Heart J Case Rep ISSN: 2514-2119
| 69-Year-old obese, diabetic, and asthmatic woman | |
|---|---|
| 2003 | Non-ST-elevation myocardial infarction (NSTEMI) Killip Class I: coronary angiography showed one vessel disease treated with left anterior descending coronary artery (LAD) stenting |
| 2016 | NSTEMI Killip Class I: coronary angiography showed non-significant in-stent restenosis and severe lesion at a marginal branch of left circumflex treated with drug-eluting stent |
| 2019 | NSTEMI Killip Class III: coronary angiography showed diffuse in-stent LAD restenosis with positive haemodynamic invasive testing. Intracoronary imaging with intravascular ultrasound revealed severe calcified neoatherosclerosis. Plaque modification with intracoronary lithotripsy was performed. Balloon rupture occurred during treatment and distal embolization resolved with the retrieval of the balloon and intracoronary nitroprussiate administration |
| 2020 | Uneventful at 12 months of follow-up |